Skip to main content
. 2022 May 4;23:34. doi: 10.1186/s12863-022-01052-y

Table 1.

Geographical locations of SARS-CoV-2 specimens and cases

Nation Specimens (S) Cases (C) Ratio (S/C)
United States 1,816,065 73,958,288 2.4%
United Kingdom 1,307,360 17,405,439 7.5%
Germany 276,777 9,978,146 2.7%
Switzerland 99,615 2,268,533 4.3%
Australia 13,312 2,182,390 0.6%
Slovakia 10,409 1,022,784 1.0%
Iceland 5,365 67,594 7.9%
Bahrain 4,946 374,575 1.3%
Kenya 4,013 321,381 1.2%
Mexico 2,950 5,198,891  < 0.1%
Denmark 2,599 1,742,569 0.1%
India 2,552 41,469,499  < 0.1%
New Zealand 2,427 16,246 14.9%
Japan 2,195 2,730,828  < 0.1%
Hong Kong 1,853
France 1,712 18,634,317  < 0.1%
Estonia 1,681 344,060 0.4%
Netherlands 1,562 4,420,834  < 0.1%
Puerto Rico 1350 457,501 0.2%
Bangladesh 1,233 1,811,987  < 0.1%
Poland 1,219 4,925,158  < 0.1%
Spain 1,184 10,100,109  < 0.1%
Brazil 1,121 25,348,797  < 0.1%
Thailand 1,106 2,447,964  < 0.1%
Saudi Arabia 1,090 687,264 0.1%
Egypt 1,072 425,911 0.2%
Italy 1,063 10,983,116  < 0.1%

Nations providing one thousand or more specimens are listed. The numbers of specimens and cases were obtained from different data sources (NCBI Virus SARS-CoV-2 Data Hub and WHO Coronavirus Dashboard databases, respectively). Therefore, these specimens are not necessarily included in the number of cases